AP: Voluntary removal of popular cold-and-cough medications from store shelves fuels conspiracy theories
The University of Cincinnati's Michael Hegener recently contributed to an Associated Press fact check debunking a claim that cold medicines being pulled off of pharmacy shelves were part of a larger conspiracy.
An FDA advisory committee agreed unanimously in September that an ingredient called phenylephrine found in many over-the-counter cold medicines called phenylephrine doesn't work to clear nasal congestion when taken orally. Since then, some medicines containing phenylephrine as its only active ingredient have been removed from CVS store shelves.
Some on social media have raised suspicions that the medication removals are due to a larger conspiracy to force people to receive COVID-19 vaccinations, but Hegener and other health experts said the theory has no merit.
“While some may find the timing of this FDA advisory committee conclusion being released during the cold and flu season to be less than ideal, hopefully it prompts patients to speak with their health care providers about other options that may actually be more effective for them,” Hegener, an associate professor of pharmacy at UC's James L. Winkle College of Pharmacy, wrote to the AP.
Even as certain medications are being removed, there are still plenty of options for cough and cold medicines that contain other active ingredients that are still effective. While these medications help treat symptoms like congestion, they do not prevent illness like a flu vaccine would.
Featured photo at top of woman looking at over the counter medicine in a pharmacy aisle. Photo/iStock/SDI Productions.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.